Aktsiaselts CHEMI-PHARM

10140819

General info

Name

Aktsiaselts CHEMI-PHARM

Registry code

10140819

VAT number

EE100310771

Type

AS - Joint Stock Company

Status

Registered

Foundation date

16.04.1997 (27)

Financial year

01.01-31.12

Capital

25 600.00 €

Activity

21201 - Manufacture of pharmaceutical preparations 74901 - Other professional, scientific and technical activities n.e.c. 46901 - Non-specialised wholesale trade 20411 - Manufacture of soap and detergents, cleaning and polishing preparations

Revenue

11 451 568 €

Profit

-

Profit margin

-

Gross salary

-

Equity

-

Employees

64

Annual report

Submitted

Tax arrears

No tax arrears

Return on equity

-

Return on assets

-

Related parties

Owner Representative Beneficial owner Roles

Chemilex OÜ

16673409

30% - 7 680.00 EUR - - Shareholder

Chemi-Pharm holding OÜ

16694950

70% - 17 920.00 EUR - - Shareholder

Ruth Oltjer

22.10.1959 (65)

- Board member Direct ownership

Reza Yeganeh Khonsari

28.05.1981 (43)

- Board member -

Andres Oltjer

04.03.1958 (66)

- - Indirect ownership Chairman of the board

Ivari Koppel

12.06.1984 (40)

- - - Board member

Kristo Timberg

02.02.1988 (36)

- - - Board member

Robert Kitt

26.04.1977 (47)

- - - Board member

Britta Oltjer

09.09.1982 (42)

- - - Board member

Gretta Oltjer-Timberg

21.05.1989 (35)

- - - Board member

Merle Vacker

19.02.1970 (54)

- - - Board member

Related companies

Owner Representative Beneficial owner Roles

Osaühing ROSTHERNE

10449008

100% - 2 556.00 EUR - -

PK Technologies OÜ

16328665

10% - 255.60 EUR - -

Nordic Tersus Laboratory OÜ

12561442

- - - Founder

Osaühing Chemi-Pharm Group

10449072

- - - Founder

Financial info

2019
22.05.2020
2020
03.06.2021
2021
30.06.2022
2022
30.06.2023
2023
28.06.2024
Total Revenue 6 859 249 € 18 479 363 € 15 495 778 € 12 868 974 € 11 451 568 €
Net profit (loss) for the period 145 812 € 4 582 645 € - - -
Profit Margin 2% 25% - - -
Current Assets 2 528 028 € 7 203 245 € - - -
Fixed Assets 1 935 590 € 2 109 975 € - - -
Total Assets 4 463 618 € 9 313 220 € 19 056 013 € 16 983 280 € 13 870 939 €
Current Liabilities 656 879 € 1 157 472 € - - -
Non Current Liabilities 186 499 € 121 085 € - - -
Total Liabilities 843 378 € 1 278 557 € - - -
Share Capital 25 600 € 25 600 € - - -
Equity 3 620 240 € 8 034 663 € - - -
Employees 49 62 81 67 64

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q1 4 095 121.41 € 191 855.12 € 293 387.59 € 63
2023 Q4 3 919 378.17 € 205 824.76 € 248 835.19 € 66
2023 Q3 3 324 732.14 € 247 502.57 € 260 675.96 € 60
2023 Q2 3 556 786.29 € 205 226.67 € 266 320.2 € 63
2023 Q1 3 537 638.43 € 141 005.31 € 289 445.06 € 67
2022 Q4 3 636 025.6 € 303 212.4 € 284 354.72 € 70
2022 Q3 3 529 352.82 € 315 031.14 € 292 656.97 € 71
2022 Q2 4 680 873.32 € 309 399.81 € 300 260.42 € 78
2022 Q1 4 450 489.11 € 307 697.24 € 313 110.04 € 79
2021 Q4 4 906 264.97 € 322 686 € 279 983.54 € 78
2021 Q3 3 638 392.1 € 373 203.7 € 294 336.56 € 79
2021 Q2 4 675 374.75 € 468 222.93 € 291 190.35 € 86
2021 Q1 5 295 234.82 € 151 773.98 € 314 381.5 € 87
2020 Q4 6 142 676.77 € 72 451.23 € 249 035.83 € 89
2020 Q3 5 809 136.52 € 201 702.67 € 245 091.57 € 75
2020 Q2 5 873 634.12 € 273 525.05 € 227 056.01 € 61
2020 Q1 2 235 537.09 € 129 032.15 € 173 885.28 € 56